Extracellular vesicles (EVs) are gaining increasing attention for diagnostic and therapeutic
applications in various diseases. These natural nanoparticles benefit from favorable safety …

Exosomes have emerged as a promising cell-free therapeutic approach. However,
challenges in large-scale production, quality control, and heterogeneity must be overcome …

Extracellular vesicles (EVs) are promising carriers for the delivery of a variety of chemical
and biological drugs. However, their efficacy is limited by the lack of cellular specificity …

Extracellular vesicles (EVs) are gaining ground as next-generation drug delivery modalities.
Genetic fusion of the protein of interest to a scaffold protein with high EV-sorting ability …

Immunotherapy has become a promising research “hotspot” in cancer treatment.“Soldier”
immune cells are not uniform throughout the body; they accumulate mostly in the immune …

Extracellular vesicles (EVs) are efficient natural vehicles for intercellular communication and
are under extensive investigation for the delivery of diverse therapeutics including small …

Neurodegenerative diseases (NDs) have a slow onset and are usually detected late during
disease. NDs are often difficult to cure due to the presence of the blood–brain barrier (BBB) …

Extracellular vesicles (EVs) derived from mesenchymal stem cells are promising
nanotherapeutics in liver diseases due to their regenerative and immunomodulatory …

Abstract The International Society for Cell & Gene Therapy Scientific Signature Series event
“Therapeutic Advances With Native and Engineered Human EVs” took place as part of the …

Extracellular vesicles (EVs) are nanoscale bilayer phospholipid membrane vesicles
released by cells. Contained large molecules such as nucleic acid, protein, and lipid, EVs …